Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$56.80 2.04 (3.73%) as of 4:30 Wed 5/22


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 4.01(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $38.62 - $89.12
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 61,438 159,721 184,721 409,721
Total Sell Value $4,291,798 $10,834,513 $12,456,407 $25,314,056
Total People Sold 3 3 3 3
Total Sell Transactions 7 12 13 22
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 483
  Page 11 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Vertex Pharmaceuticals Inc / Ma 10% Owner   –       –       •   2018-12-26 4 B $24.89 $317,077 D/D 12,737 5,353,479 2.45     -
   Vertex Pharmaceuticals Inc / Ma 10% Owner   –       –       •   2018-12-24 4 B $22.91 $1,671,482 D/D 68,000 5,340,742 2.45     -
   Vertex Pharmaceuticals Inc / Ma 10% Owner   –       –       •   2018-12-21 4 B $22.58 $513,478 D/D 22,742 5,272,742 2.45     -
   Emster Kurt Von Director   –       •      –    2018-12-18 4/A S $29.70 $1,869,168 I/I (62,925) 1,171,268     -
   Emster Kurt Von Director   –       •      –    2018-12-18 4 S $29.70 $2,077,101 I/I (69,925) 1,164,268     -
   Emster Kurt Von Director   –       •      –    2018-12-17 4 S $33.17 $99,797 I/I (3,009) 1,234,193     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2018-12-07 4 OE $1.81 $38,915 D/D 21,500 167,290     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2018-12-01 4 D $38.33 $28,403 D/D (741) 145,790     -
   Celgene Corp /de/ 10% Owner   –       –       •   2018-11-21 4 S $19.25 $1,540,000 I/I (80,000) 4,173,019     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2018-09-01 4 D $56.67 $41,992 D/D (741) 146,531     -
   Ho Tony W See Remarks   •       –      –    2018-08-02 4 D $48.43 $708,579 D/D (14,631) 22,869     -
   Ho Tony W See Remarks   •       –      –    2018-08-01 4 OE $0.00 $0 D/D 37,500 37,500     -
   Cagnoni Pablo J Director   –       •      –    2018-07-05 4 AS $62.00 $104,408 D/D (1,684) 0     -
   Cagnoni Pablo J Director   –       •      –    2018-07-05 4 OE $5.59 $9,414 D/D 1,684 1,684     -
   Cagnoni Pablo J Director   –       •      –    2018-07-03 4 AS $62.00 $360,592 D/D (5,816) 0     -
   Cagnoni Pablo J Director   –       •      –    2018-07-03 4 OE $5.59 $32,511 D/D 5,816 5,816     -
   Emster Kurt Von Director   –       •      –    2018-06-05 4 S $12.51 $11,509 I/I (920) 18,316     -
   Emster Kurt Von Director   –       •      –    2018-06-05 4 OE $5.75 $11,500 I/I 2,000 19,236     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2018-06-04 4 D $67.13 $49,743 D/D (741) 147,819     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2018-06-01 4 AS $67.28 $1,040,400 D/D (15,000) 148,560     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2018-06-01 4 OE $1.81 $27,150 D/D 15,000 163,560     -
   Novak Rodger President   •       •      –    2018-05-17 4 AS $60.00 $4,500,000 D/D (75,000) 1,148,007     -
   Novak Rodger President   •       •      –    2018-05-17 4 OE $1.81 $620,424 D/D 75,000 1,223,007     -
   Bolzon Bradley J Phd Director   –       •      –    2018-05-15 4 S $57.97 $2,551,440 I/I (44,000) 640,014     -
   Woiwode Thomas Director   –       •      –    2018-05-15 4 S $57.97 $2,551,440 I/I (44,000) 640,014     -
  483 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us